EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Anxiolytic Effect of Ondansetron in Swiss Albino Mice

V. Arunkokil, L. Madhan, N. Preetha

International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)

DOI: 10.25258/ijcpr.18.6.140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von V. Arunkokil und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anxiety disorders are among the most prevalent psychiatric conditions worldwide, affecting approximately one-eighth of the global population [1]. Current pharmacological management predominantly relies on benzodiazepines, azapirones, selective serotonin reuptake inhibitors (SSRIs), and beta-blockers, many of which are associated with sedation, dependence, and abuse potential [3]. Ondansetron, a selective 5-HT3 receptor antagonist, modulates serotonergic neurotransmission through allosteric inhibition and represents a promising candidate for anxiolytic therapy with a potentially superior tolerability profile. Objective of this study is to evaluate and compare the anxiolytic activity of ondansetron at two dose levels (0.5 mg/kg and 1 mg/kg, oral) against alprazolam (0.25 mg/kg, oral) as the standard drug, using three validated rodent behavioural models in Swiss albino mice.

Methods

Twenty-four adult Swiss albino mice were randomly divided into four groups (n=6 each). Group I received distilled water (0.4 ml oral, control); Group II received alprazolam 0.25 mg/kg oral (standard); Group III received ondansetron 0.5 mg/kg oral; and Group IV received ondansetron 1 mg/kg oral. Drugs were administered for seven consecutive days, after which behaviour was assessed using the Elevated Plus Maze (EPM), Open Field Test (OFT), and Hole Board Apparatus Test (HBT). One-way ANOVA followed by Tukey's post-hoc test was used for statistical analysis.

Results

Ondansetron at 1 mg/kg significantly increased time spent in the open arm (159.33 ± 12.37 sec) and reduced time in the closed arm (140.67 ± 12.37 sec) on EPM, comparable to alprazolam (154.50 ± 12.36 sec; 145.50 ± 12.36 sec). Similarly, ondansetron 1 mg/kg increased locomotor activity (88.17 ± 6.76 squares), time spent in the centre square (76.00 ± 4.86 sec) on OFT, and head-poking frequency (10.48 ± 1.47) on HBT. Oneway ANOVA revealed highly significant differences across all parameters (F values 31.66–115.79; p < 0.00001). Post-hoc analysis showed no significant difference between ondansetron 1 mg/kg and alprazolam 0.25 mg/kg, confirming equipotent anxiolytic activity.

Conclusion

Ondansetron demonstrates significant dose-dependent anxiolytic activity in Swiss albino mice, with the higher dose (1 mg/kg) producing effects comparable to the standard benzodiazepine alprazolam. This positions ondansetron as a potential anxiolytic agent warranting further clinical evaluation.

Zitieren

APA

Arunkokil, V., Madhan, L., & Preetha, N. (2026). Evaluation of Anxiolytic Effect of Ondansetron in Swiss Albino Mice. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.140

Vancouver

Arunkokil V, Madhan L, Preetha N. Evaluation of Anxiolytic Effect of Ondansetron in Swiss Albino Mice. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.140

BibTeX
@article{Arunkokil2026,
  author = {Arunkokil, V. and Madhan, L. and Preetha, N.},
  title = {Evaluation of Anxiolytic Effect of Ondansetron in Swiss Albino Mice},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {06},
  doi = {10.25258/ijcpr.18.6.140}
}
Kostenlos starten →